Aug 2026· JMA Journal· Vol 9, pp. 1036 - 1043· 0 citations· 36 references
Medicine
Abstract
Cancer-associated fibroblasts (CAFs) are key regulators of tumor progression, immune modulation, and therapeutic resistance within the tumor microenvironment. Advances in single-cell and spatial profiling have revealed substantial heterogeneity among CAF populations, challenging the traditional view of CAFs as a uniformly tumor-promoting stromal population. Among the identified fibroblast states, antigen-presenting CAFs (apCAFs) represent a distinct subset characterized by major histocompatibility complex class II expression and the ability to directly interact with cluster of differentiation (CD) 4+ T cells. First described in pancreatic ductal adenocarcinoma, apCAFs have since been observed in multiple tumor types. Unlike professional antigen-presenting cells, apCAFs lack classical costimulatory molecules, suggesting that their antigen presentation leads to non-canonical immune outcomes, including immune modulation, immune tolerance, or regulatory T cell induction. Recent evidence indicates that apCAFs arise from multiple cellular sources, most prominently mesothelial cells undergoing mesothelial-to-mesenchymal transition in response to tumor-derived signals such as interleukin-1 and transforming growth factor-β. Additional studies have identified fibrocyte-like apCAFs derived from bone marrow–derived cells, underscoring the heterogeneous and context-dependent nature of this fibroblast state. Consistent with their antigen-presenting capacity, apCAFs localize to immune-enriched niches, including tertiary lymphoid structures, where they influence local immune architecture and T cell functional states. Notably, apCAFs have been linked to both tumor-promoting and tumor-restraining activities, highlighting their dual roles in cancer immunity. Importantly, these immunological functions have direct clinical implications: apCAF-enriched stromal programs are associated with distinct immune landscapes and may influence responses to immune checkpoint blockade. This review summarizes current knowledge of the biology of apCAFs, with emphasis on their defining molecular features, cellular origins, immunological functions, and clinical relevance. Therefore, defining the context-dependent roles of apCAFs will be essential for designing next-generation stromal-targeted and immunotherapy-combination strategies that selectively enhance antitumor immunity while limiting tumor-promoting fibroblast functions.
Cancer-associated fibroblasts (CAFs) are key regulators of tumor progression and therapeutic response in pancreatic ductal adenocarcinoma (PDAC). While CAF-mediated immune modulation has been extensively studied, it remains poorly understood whether adaptive immune cells reciprocally shape CAF heterogeneity and funct...
Jessica Hung, Stephanie L. Silveria, Jenna Vickery et al.· Cancer Research· 0 citations
Cancer-associated fibroblasts (CAFs) exhibit remarkable functional heterogeneity, with conserved subtypes observed across diverse malignancies. However, their shared roles in shaping the tumor microenvironment (TME) and their dynamic plasticity remain incompletely understood. In this study, through integrated single-ce...
Fei-Fei Song, Qi Chen, Deng-Feng Huang et al.· Signal Transduction and Targ...· 0 citations
The tumor microenvironment (TME) represents a complex, dynamic, and heterogeneous system in which stromal and immune elements interact to influence tumor development and mechanisms of immune escape. Within the stromal compartment, cancer-associated fibroblasts (CAFs) have been identified as key mediators of immune regu...
D. Zinovkin, Y. Korneva, H. Arafat et al.· Frontiers in Immunology· 0 citations
A context-dependent framework integrating macrophage heterogeneity, immunometabolism, spatial biology, biomarker development, and therapeutic decision-making to advance precision immunotherapy is proposed.
Xue-Jun Guo, Jing-Ya Yu, Xiao-Yan Lin et al.· Critical reviews in oncology...· 1 citation
: Gastric cancer is a leading cause of cancer-related death worldwide; among its progression patterns, peritoneal metastasis (PM) has the poorest prognosis. PM lesions show strong resistance to immune checkpoint inhibitors (ICIs), and the molecular basis of this resistance remains poorly understood. The aim of this rev...
J. Kinoshita, S. Fushida, N. Inaki· Oncology Research· 0 citations
Antigen-presenting cancer-associated fibroblasts (apCAFs), commonly defined by MHC class II molecules, CD74, and related transcriptional programs, exhibit divergent functions across gastrointestinal tumors. In pancreatic ductal adenocarcinoma, mesothelium-derived apCAFs promote regulatory T-cell differentiation and s...